Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated Protein Kinase (AMPK) Activators
Pradip K. Sasmal, Mahaboobi Jaleel, P. Tirumala Rao, M. Munikumar, Megha Bhattacharya, Nutakki Ravi Kumar, Poondla. Neelima, Khaji Abdul Rawoof, P. Narasimha Rao, Chandrasekhar Abbineni, M. Roshaiah, S. Sridhar, Thammera Ranjith Kumar, Menon C. A. Vinu, Vijay Potluri, Parimal Misra, Rashmi Talwar and Saibal Kumar DasAffiliation:
Dr. Reddy's Laboratories Ltd., Proprietary Products, Innovation Plaza, Bachupally, Hyderabad 500090, India.
AbstractAdenosine 5’-monophosphate (AMP) activated protein kinase (AMPK) is a highly conserved sensor of cellular energy. AMPK has been recognized as a key regulator of mammalian metabolic function and has emerged as an attractive target for the treatment of metabolic disorders, including obesity and type 2 diabetes. The synthesis and biological evaluation of novel 3-(4-oxothieno[2,3-d]pyrimidin-3(4H)-yl)propanoic acid derivatives as AMPK activators are described. The in vivo proof of principle for plasma glucose lowering effect is exemplified with a lead compound from this series.
AMP-activated protein kinase (AMPK), AMPK activators, Thienopyrimidinone derivatives, Type-2 diabetes mellitus, db/db mice model.
Purchase Online Order Reprints Order Eprints Rights and Permissions